Myorix Cyclobenzaprine 15-30mg 14 capsules

Composition
active substance: cyclobenzaprine hydrochloride;

1 capsule contains 15 mg of cyclobenzaprine hydrochloride;

auxiliary substances: spherical sugar, opadry clear YS-1-7006, ethyl cellulose, diethyl phthalate;

capsule shell of 15 mg: iron oxide red (E 172), iron oxide yellow (E 172), titanium dioxide (E 171), gelatin, blue ink TekPrintTM SB-6018.

Pharmacotherapeutic group
Muscle relaxants. Other muscle relaxants of central action.

ATX code M03B X08.

Indication
Elimination of muscle spasm, accompanied by acute pain from the musculoskeletal system, as a supplement to the regimen of limited physical activity and physical therapy. Improvement is manifested by resolution of muscle spasms and associated signs and symptoms, such as pain, tenderness, and restricted movement.

Method of application and dosage
The recommended dose for adults is 15 mg (1 capsule of  15 mg) once a day. Some patients need an increase in the dose to 30 mg once a day (1 capsule of  30 mg or 2 capsules of  15 mg).

The drug is taken every day at approximately the same time.

It is not recommended to use for more than 2-3 weeks.

Elderly patients (65 years and older). There are not enough clinical studies on the use of  in this category of patients. The use of  in elderly patients is not recommended.

Patients with liver failure. The use of  is not recommended for patients with mild, moderate or severe liver failure (see the section “Particulars of use”).